Metoclopramide for Post-Traumatic Headache. A Pilot Study
Sponsor: Montefiore Medical Center
This PHASE1/PHASE2 trial investigates Post-Traumatic Headache and is currently completed. Montefiore Medical Center leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Aug 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE1_PHASE2
-
Apr 2018 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
Status: Recruiting → Completed · Phase: EARLY_PHASE1 → PHASE1_PHASE2
-
Jun 2017 — Apr 2018 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Montefiore Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .